Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009
about
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directionsOpioid overdose prevention and naloxone rescue kits: what we know and what we don't knowDrug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner's CasesMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesCost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study.Primary Care Patient Experience with Naloxone Prescription.How health care reform can transform the health of criminal justice-involved individualsThe SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.A behavioral typology of opioid overdose risk behaviors among recent veterans in New York City.Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependencePrison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysisCorrelates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners.Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional studyAttitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.A patient navigation intervention for drug-involved former prison inmates.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Optimizing continuity of care throughout incarceration: case and opportunitiesChallenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.Incarceration and injection drug use in Baltimore, Maryland.Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.Access to primary care in adults in a provincial correctional facility in Ontario.Cancer prevalence, incidence and mortality in people who experience incarceration in Ontario, Canada: A population-based retrospective cohort studyReceipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.Clinical risk factors for death after release from prison in Washington State: a nested case-control study.Mortality over 12 years of follow-up in people admitted to provincial custody in Ontario: a retrospective cohort study.Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort StudyA Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO.Novel interventions to prevent HIV and HCV among persons who inject drugs.High risk of overdose death following release from prison: variations in mortality during a 15-year observation period.Suicide Risk in Young Men and Women After Substance Intoxication.Risk Factors for Severe Respiratory Depression from Prescription Opioid Overdose.Opioid-Involved Overdose Among Male Afghanistan/Iraq-Era U.S. Military Veterans: A Multidimensional Perspective.Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego.Incarceration History and Uncontrolled Blood Pressure in a Multi-Site Cohort.Injectable pharmacotherapy for opioid use disorders (IPOD).
P2860
Q26746195-76DACD4D-9ED6-4B89-B00D-F6D80C167D2EQ28365114-6E5D0B35-A600-487C-90C8-5D92C643C32CQ28552395-35941EE9-7A7D-4387-A92C-1DC1F3982BA2Q30234647-E3B58CA7-62B3-43A2-8944-D01AB7491856Q30253083-02D6073E-AB36-4B39-981A-FC632291F5E8Q30277067-612D7E4D-090A-405D-AA4A-7C98C55C81D9Q30300924-7A9F3C32-A595-4DE3-97B6-40F0D4B9E197Q30387588-62F6D083-2BCA-4143-AFFB-F50D11D8286EQ33572144-0041E236-77F3-496D-A9D0-FCC4D652AE8CQ33668626-E986E478-AFD9-41B8-93D5-8BA9165C0CE0Q33754693-15E0AF4E-5FBA-4DAA-91FB-9774D7973F8AQ33778689-8D5CE3B9-2C4E-4784-9D5B-BD1B5F684A35Q33783250-4A150A15-1A64-4BAF-9253-8F9A5D60FDF8Q34006558-D6978A64-CBD0-49D0-ABE4-8562E1A49089Q34169506-19DC9C26-3068-4D5F-8DAE-B8764CE0C2FAQ34587153-76DE54CD-EC86-469C-A74F-05AB1C5AEDF1Q34676524-C35C9327-0BB8-4462-B0F4-1B5FCE51A54CQ34772591-FDDC9E9A-14EC-430F-87D3-4944338D981EQ34817072-7A5FBE07-C0C3-423C-8850-ABB7DD083EADQ35077066-38134304-2C55-4AF3-A064-AFFC546E08C0Q35088386-BB56DB5A-F447-42CD-BA6E-AA740A6E7E3AQ35163178-7C16B2CD-48AD-4C6C-B085-22522A35AA33Q35540686-EF4E9161-B2D1-46F3-AA73-8873DD219094Q35772448-27C68AC6-463C-48AC-8F89-3C88D02F69E9Q35855231-57FC3875-4F1A-4E0E-9FBA-944A8FD2FA91Q35938939-D015FE57-5A55-4B9B-A601-A59047C1D3A9Q36287391-4F4E2080-5270-4D75-83B3-5EBCDA3D2425Q36619578-4DDAA27D-A3BD-47F9-8772-BFC7967AE4A5Q36805659-B345B422-39EA-4C56-9CDA-B3859F57945DQ37066903-69200CF9-A028-47F8-B4F2-84EA29A8433EQ37075726-BA274B3F-91AC-4B87-B205-F4D953C3041CQ37710111-596AD9DD-093E-4A87-9F6A-5101F58A7436Q38318678-047BB0E8-5047-44BE-BDA2-B27FA945AA5DQ38402158-ABC6E302-1D3E-4648-BD27-68850EBCC64FQ38679315-7565D206-DC5A-4D2E-A7D6-75AB0F4AA560Q38711031-F7FD1B33-64B8-47E1-B89B-1BEB95109AA8Q38722413-6A0E0244-24B7-4D2B-8F13-CE729AC436AAQ39006648-F1818AFA-A867-4489-A6D3-24AA26D1452CQ39399374-0F0035D1-83A2-4FA0-8D47-E862B686B786Q39696141-0399C6E7-812B-4415-BEE0-35D980AEE838
P2860
Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mortality after prison release ...... time trends from 1999 to 2009
@ast
Mortality after prison release ...... time trends from 1999 to 2009
@en
Mortality after prison release ...... time trends from 1999 to 2009
@nl
type
label
Mortality after prison release ...... time trends from 1999 to 2009
@ast
Mortality after prison release ...... time trends from 1999 to 2009
@en
Mortality after prison release ...... time trends from 1999 to 2009
@nl
prefLabel
Mortality after prison release ...... time trends from 1999 to 2009
@ast
Mortality after prison release ...... time trends from 1999 to 2009
@en
Mortality after prison release ...... time trends from 1999 to 2009
@nl
P2093
P2860
P3181
P1476
Mortality after prison release ...... time trends from 1999 to 2009
@en
P2093
Marc F Stern
Patrick J Blatchford
Shane R Mueller
P2860
P304
P3181
P356
10.7326/0003-4819-159-9-201311050-00005
P407
P577
2013-11-01T00:00:00Z